The GOLMePsA study protocol: an investigator-initiated, double-blind, parallel-group, randomised, controlled trial of GOLimumab and methotrexate versus methotrexate in early diagnosed psoriatic arthritis using clinical and whole body MRI outcomes
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2474
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The GOLMePsA study protocol: an investigator-initiated, double-blind, parallel-group, randomised, controlled trial of GOLimumab and methotrexate versus methotrexate in early diagnosed psoriatic arthritis using clinical and whole body MRI outcomes ; volume:18 ; number:1 ; day:18 ; month:7 ; year:2017 ; pages:1-13 ; date:12.2017
BMC musculoskeletal disorders ; 18, Heft 1 (18.7.2017), 1-13, 12.2017
- Keyword
-
Orthopädie
- Creator
-
De Marco, Gabriele
- Contributor
-
Helliwell, Philip
McGonagle, Dennis
Emery, Paul
Coates, Laura C.
Hensor, Elizabeth M. A.
Marzo-Ortega, Helena
SpringerLink (Online service)
- DOI
-
10.1186/s12891-017-1659-1
- URN
-
urn:nbn:de:1111-201708215569
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- De Marco, Gabriele
- Helliwell, Philip
- McGonagle, Dennis
- Emery, Paul
- Coates, Laura C.
- Hensor, Elizabeth M. A.
- Marzo-Ortega, Helena
- SpringerLink (Online service)
Other Objects (12)
Methotrexate
Prevalence of methotrexate intolerance in rheumatoid arthritis and psoriatic arthritis
Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial
High-dose Methotrexate
METHOTREXATE INDUCED LEUCOENCEPHALOPATHY
Guide for investigator initiated trials
Erratum to: Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial
Comparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis: protocol of a randomized, placebo-controlled, double-blind clinical trial (COMPLETE-PsA)
Potential neurotoxicity associated with methotrexate
Methotrexate intolerance in Rheumatoid Arthritis
Methotrexate-Related Pancytopenia: A Case Report
Methotrexate-Associated Lymphoproliferative Disorder: Dermoscopic Features
Methotrexate
Prevalence of methotrexate intolerance in rheumatoid arthritis and psoriatic arthritis
Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial
High-dose Methotrexate
METHOTREXATE INDUCED LEUCOENCEPHALOPATHY
Guide for investigator initiated trials
Erratum to: Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial
Comparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis: protocol of a randomized, placebo-controlled, double-blind clinical trial (COMPLETE-PsA)
Potential neurotoxicity associated with methotrexate
Methotrexate intolerance in Rheumatoid Arthritis
Methotrexate-Related Pancytopenia: A Case Report
Methotrexate-Associated Lymphoproliferative Disorder: Dermoscopic Features
Methotrexate
Prevalence of methotrexate intolerance in rheumatoid arthritis and psoriatic arthritis
Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial
High-dose Methotrexate
METHOTREXATE INDUCED LEUCOENCEPHALOPATHY
Guide for investigator initiated trials
Erratum to: Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial
Comparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis: protocol of a randomized, placebo-controlled, double-blind clinical trial (COMPLETE-PsA)
Potential neurotoxicity associated with methotrexate
Methotrexate intolerance in Rheumatoid Arthritis
Methotrexate-Related Pancytopenia: A Case Report